Literature DB >> 3061367

Immunoglobulin A in the skin of patients with ankylosing spondylitis.

A Collado1, R Sanmarti, I Bielsa, T Castel, E Kanterewicz, J D Cañete, M A Brancós, J Rotes-Querol.   

Abstract

Cutaneous immunofluorescence studies were carried out in 21 patients with ankylosing spondylitis (AS) and the results compared with those for 18 healthy subjects. The most prominent finding was the presence of IgA in dermal vessels of patients with AS (71% compared with 17% of the control group). IgG and IgM cutaneous deposits were also observed in patients with AS, but these results did not differ from those of the control group. A renal biopsy was performed in three of the patients presenting with unexplained microscopic haematuria. One of them had an IgA nephropathy, but no correlation was found between kidney and skin deposits of IgA. These findings suggest that IgA cutaneous deposits in AS are not a marker of IgA nephropathy but stress the role of immunoglobulin A in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3061367      PMCID: PMC1003655          DOI: 10.1136/ard.47.12.1004

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

Review 1.  The immunopathology of ankylosing spondylitis--a review.

Authors:  L E McGuigan; A F Geczy; J P Edmonds
Journal:  Semin Arthritis Rheum       Date:  1985-11       Impact factor: 5.532

2.  Immunoglobulin A and C reactive protein levels in ankylosing spondylitis.

Authors:  A Collado; R Sanmarti; M A Brancós; E Kanterewicz; T Gallart; J Rotés-Querol; A Cobos
Journal:  Ann Rheum Dis       Date:  1987-09       Impact factor: 19.103

3.  High association of an HL-A antigen, W27, with ankylosing spondylitis.

Authors:  L Schlosstein; P I Terasaki; R Bluestone; C M Pearson
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

4.  Significance of microhaematuria in young adults.

Authors:  K T Woo; R P Edmondson; E J Lee; G S Chiang; C H Lim
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-17

5.  IgA serum levels and disease activity in ankylosing spondylitis: a prospective study.

Authors:  M J Franssen; L B van de Putte; F W Gribnau
Journal:  Ann Rheum Dis       Date:  1985-11       Impact factor: 19.103

6.  Immune deposits in the skin of patients with rheumatoid arthritis.

Authors:  P E McGill; P A Brougham; J Tulloch
Journal:  J Rheumatol       Date:  1984-08       Impact factor: 4.666

7.  Association of inflammation with raised serum IgA in ankylosing spondylitis.

Authors:  P Cowling; R Ebringer; A Ebringer
Journal:  Ann Rheum Dis       Date:  1980-12       Impact factor: 19.103

8.  Increased incidence of recurrent hematuria in ankylosing spondylitis: a possible association with IgA nephropathy.

Authors:  B A Wall; C A Agudelo; E J Pisko
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

9.  Direct immunofluorescence of normal skin in rheumatoid arthritis.

Authors:  O M Fitzgerald; L Barnes; R Woods; L McHugh; C Barry; S O'Loughlin
Journal:  Br J Rheumatol       Date:  1985-11

10.  Immunofluorescence patterns in sun-exposed and not-sun-exposed skin of healthy individuals.

Authors:  C Nieboer
Journal:  Acta Derm Venereol       Date:  1981       Impact factor: 4.437

View more
  9 in total

1.  Enumeration of IgA producing cells by the enzyme linked immunospot (ELISPOT) technique to evaluate sulphasalazine effects in inflammatory arthritides.

Authors:  N Feltelius; S Gudmundsson; L Wennersten; O Sjöberg; R Hällgren; L Klareskog
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

2.  Bronchoalveolar lavage in ankylosing spondylitis.

Authors:  D Wendling; J C Dalphin; B Toson; A Depierre; M Guidet
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

3.  Serum secretory immunoglobulins in ankylosing spondylitis.

Authors:  D Wendling; J M Didier; E Seilles
Journal:  Clin Rheumatol       Date:  1996-11       Impact factor: 2.980

4.  Henoch-Schonlein purpura associated with HLA-B27 positive axial spondyloarthritis in a young man.

Authors:  Kevin John John; Mohammad Sadiq; Meera Thomas; Vijay Prakash Turaka
Journal:  BMJ Case Rep       Date:  2019-05-24

5.  Microcirculation in ankylosing spondylitis.

Authors:  D Wendling; J C Risold
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

6.  Systemic vasculitis associated with seronegative spondylarthropathy (Reiter's syndrome).

Authors:  U Boehni; B Christen; P Greminger; B A Michel
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

7.  Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease?

Authors:  Bayram Farisogullari; Muserref Kasap Cuceoglu; Hakan Oral; Gozde Kubra Yardimci; Yelda Bilginer; Seza Ozen; Omer Karadag
Journal:  Intern Emerg Med       Date:  2022-03-26       Impact factor: 5.472

8.  IgA1 and IgA2 subclass antibodies against Klebsiella pneumoniae in the sera of patients with peripheral and axial types of ankylosing spondylitis.

Authors:  O Mäki-Ikola; M Nissilä; K Lehtinen; M Leirisalo-Repo; K Granfors
Journal:  Ann Rheum Dis       Date:  1995-08       Impact factor: 19.103

9.  Can ultrasound be an assessment tool for sagittal spine mobility and chest expansion in patients with ankylosing spondylitis?

Authors:  Ozan Volkan Yurdakul; Aylin Rezvani
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.